LIM domain-binding protein 1 (LDB1)

LIM domain-binding protein 1 (LDB1) is a nuclear cofactor/adaptor protein that serves as a scaffold for assembling multiprotein transcriptional regulatory complexes, particularly in association with LIM domain-containing proteins such as LMO and LIM-homeodomain (LIM-HD) factors[5][3][4]. LDB1 contains several conserved domains including a dimerization domain (DD), an LDB/Chip conserved domain (LCCD), a nuclear localization signal (NLS), and a C-terminal LIM interaction domain (LID), allowing it to interact with single-stranded DNA-binding proteins (SSBPs) and various LIM-only and LIM-homeodomain transcription factors[1][4][3]. Through these interactions, LDB1 is crucial for cell fate decisions during processes such as erythropoiesis (formation of red blood cells), neurogenesis (formation of neurons), and cardiogenesis (heart development)[1][5]. In the hematopoietic system, the LDB1-LMO2 complex is essential for the regulation of genes involved in blood cell formation and differentiation, and its dysregulation is implicated in leukemia[5]. LDB1 does not directly bind DNA, but instead, acts as an architectural factor, stabilizing transcription factor complexes and mediating long-range enhancer–promoter interactions critical for gene expression[1][3][4]. There are currently no drugs or approved therapeutic interventions specifically targeting LDB1, nor is there a well-established biomarker or safety concern profile. However, given its central role in regulating transcription factor complexes and its involvement in disease pathways, LDB1 is an active area of investigation in basic and translational research.

Other names

LIM domain-binding protein 1LDB1CLIM2LDB-1CLIM-2hLdb1NLINuclear LIM interactorCarboxyl-terminal LIM domain-binding protein 2LIM domain-binding factor CLIM2LIM domain-binding factor-1carboxy terminal LIM domain protein 2